These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32520157)

  • 1. Melatonin and organ transplantation: what is the relationship?
    Haddad CF; Haddad JM; Veiga ECA; Sorpreso ICE; Simões RS; Baracat EC; Soares Júnior JM
    Rev Assoc Med Bras (1992); 2020 Mar; 66(3):353-358. PubMed ID: 32520157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin in vivo prolongs cardiac allograft survival in rats.
    Jung FJ; Yang L; Härter L; Inci I; Schneiter D; Lardinois D; Keel M; Weder W; Korom S
    J Pineal Res; 2004 Aug; 37(1):36-41. PubMed ID: 15230866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin influence in ovary transplantation: systematic review.
    Shiroma ME; Botelho NM; Damous LL; Baracat EC; Soares JM
    J Ovarian Res; 2016 Jun; 9(1):33. PubMed ID: 27287621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential benefits of melatonin in organ transplantation: a review.
    Esteban-Zubero E; García-Gil FA; López-Pingarrón L; Alatorre-Jiménez MA; Iñigo-Gil P; Tan DX; García JJ; Reiter RJ
    J Endocrinol; 2016 Jun; 229(3):R129-46. PubMed ID: 27068700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New directions for induction immunosuppression strategy in solid organ transplantation.
    Hawksworth JS; Leeser D; Jindal RM; Falta E; Tadaki D; Elster EA
    Am J Surg; 2009 Apr; 197(4):515-24. PubMed ID: 19249743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute allograft rejection and immunosuppression: influence on endogenous melatonin secretion.
    Cardell M; Jung FJ; Zhai W; Hillinger S; Welp A; Manz B; Weder W; Korom S
    J Pineal Res; 2008 Apr; 44(3):261-6. PubMed ID: 18339121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ; McKeage K; Keam SJ; Plosker GL
    Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ruthenium (III) polyaminocarboxylate complex, a novel nitric oxide scavenger, enhances graft survival and decreases nitrosylated heme protein in models of acute and delayed cardiac transplant rejection.
    Pieper GM; Roza AM; Adams MB; Hilton G; Johnson M; Felix CC; Kampalath B; Darkes M; Wanggui Y; Cameron B; Fricker SP
    J Cardiovasc Pharmacol; 2002 Mar; 39(3):441-8. PubMed ID: 11862124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Targets for the Prevention of Chronic Rejection after Thoracic Organ Transplantation.
    Heim C; Gocht A; Weyand M; Ensminger S
    Thorac Cardiovasc Surg; 2018 Jan; 66(1):20-30. PubMed ID: 29258125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus: the good, the bad, and the ugly.
    Chand DH; Southerland SM; Cunningham RJ
    Pediatr Transplant; 2001 Feb; 5(1):32-6. PubMed ID: 11260486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alemtuzumab Induction Versus Conventional Immunosuppression in Heart Transplant Recipients.
    Gale SE; Ravichandran B; Ton VK; Pham S; Reed BN
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):435-441. PubMed ID: 31035777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everolimus: an update on the mechanism of action, pharmacokinetics and recent clinical trials.
    Sánchez-Fructuoso AI
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):807-19. PubMed ID: 18611120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Case you Missed It-Basic Science Advances in Transplantation 2017.
    Baan CC
    Transplantation; 2018 Jun; 102(6):932-934. PubMed ID: 29528966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid avoidance or withdrawal for kidney transplant recipients.
    Pascual J; Zamora J; Galeano C; Royuela A; Quereda C
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005632. PubMed ID: 19160257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry.
    Narula J; Bennett LE; DiSalvo T; Hosenpud JD; Semigran MJ; Dec GW
    Transplantation; 1997 Mar; 63(6):861-7. PubMed ID: 9089227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Melatonin in Solid Organ Transplantation-Is It Time for Clinical Trials? A Comprehensive Review.
    Stiegler P; Bausys A; Leber B; Strupas K; Schemmer P
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30413018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic aspects and rejection in solid organ versus reconstructive transplantation.
    Hautz T; Brandacher G; Zelger B; Gorantla VS; Lee AW; Pratschke J; Schneeberger S
    Transplant Proc; 2010 Nov; 42(9):3347-53. PubMed ID: 21094778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression following organ transplantation. Part 1: mechanisms and immunosuppressive agents.
    Cajanding R
    Br J Nurs; 2018 Sep; 27(16):920-927. PubMed ID: 30187798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Belatacept in Solid Organ Transplant: Review of Current Literature Across Transplant Types.
    Perez CP; Patel N; Mardis CR; Meadows HB; Taber DJ; Pilch NA
    Transplantation; 2018 Sep; 102(9):1440-1452. PubMed ID: 29787522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.